Consultant of Cardiology and Head of Heart Failure, Cardiology Department, Hospital del Mar
Dr Josep Comin-Colet received his Bachelor of Medicine and Surgery from the University of Barcelona in 1992. He was an Internal Medicine Resident in the UK (Scarborough, North Yorkshire) from 1993 until 1994. He went on to carry out specialist training in cardiology at the Hospital of Bellvitge, Barcelona, between 1996 and 2001. Dr Comin-Colet was a member of the Heart Failure and Cardiac Transplantation Team at the Hospital of Bellvitge in 2001. Since 2001, Dr Comin-Colet has been a Consultant of Cardiology at the Cardiology Department of the Hospital del Mar in Barcelona, where he is Head of the Heart Failure Section. He is also Director of the Heart Failure Programme at the Hospital del Mar. Dr Comin-Colet has also been Director of the Heart Diseases Biomedical Research Group at the Research Institute of the Hospital del Mar since 2012.
Dr Comin-Colet has been Associate Professor at the Department of Medicine, Autonomous University of Barcelona since 2003 and was Visiting Professor at the School of Public Health at Johns Hopkins University in Baltimore, Maryland, USA, in 2007. He went on to receive his PhD at the Autonomous University of Barcelona in May 2012. Dr Comin-Colet is also Past-Vice President of the Catalan Society of Cardiology and a member of the Heart Failure Association of the ESC and Advisor to the Ministry of Health of the Government of Catalonia for the organisation of care for patients with chronic conditions.
Dr Comin-Colet has given more than 200 invited lectures in courses, conferences and symposia nationally and internationally. He has more than 65 articles published in international journals of medicine and cardiology such as The New England Journal of Medicine, the European Heart Journal, the European Journal of Heart Failure, Revista Española de Cardiologia, and the Journal of Cardiac Failure. He is a reviewer for several journals in cardiology in Europe and the USA (the European Heart Journal, the American Journal of Cardiology, the Journal of Cardiac Failure, the International Journal of Cardiology, and the European Journal of Cardiovascular Nursing).
Dr Comin-Colet currently combines patient care with scientific research in various fields of cardiology and heart failure, particularly in areas of genetics, molecular medicine and applied research in the management of patients with the use of telemedicine.
Dr Comin-Colet has received consultancy honoraria from Vifor Pharma, Novartis, Menarini, Servier, and Orion. He has received honoraria as a speaker from Vifor Pharma, Novartis, Menarini, Servier Laboratories, Pfizer, Roche, Orion, and Merck Sharp & Dohme Limited.